Decreased screening rates among different subgroups highlight the ongoing need for outreach strategies that target vulnerable populations, experts contend.
Nearly 27,000 MiniMed 780G insulin pumps were included in a new Class II recall. By taking a few basic steps, however, patients should be able to avoid any significant risks.
Vascular surgeons perform procedures interventional cardiologists and interventional radiologists do not do—so why not make sure they are part of every heart team conversation?
The MSU operates 365 days a year and covers 138 square miles. Hundreds of patients have been treated through the MSU, with more than 500 receiving critical care in it 2025 alone.
Led by a Quebec-based faith organization, a coalition of investors is asking a court to force UnitedHealth to provide details on the social impacts of its history of mergers and acquisitions. The lawsuit comes after the plaintiffs, all company shareholders, failed to get the proposal passed through internal channels. The Securities and Exchange Commission has also opted not to intervene.
Ohio State University College of Medicine, Stanford University School of Medicine and UC San Diego School of Medicine all received letters this week where federal authorities are requesting details related to admissions, including standardized test scores, donor correspondence and more. The schools say they are already compliant with state and federal regulations.
Luigi Mangione, 26, has been officially charged with the murder of UnitedHealthcare CEO Brian Thompson. He awaits extradition to New York after being arrested in Pennsylvania, where he was found carrying a gun, fake IDs and a handwritten document.
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.
FDA Commissioner Robert Califf, MD, explains the need for hospitals to perform quality assurance checks on clinical artificial intelligence to ensure these technologies don't "drift" from what was originally cleared by the FDA.
